Oral mucosa as a source of Mycobacterium leprae infection and transmission, and implications of bacterial DNA detection and the immunological status

Clinical Microbiology and Infection

Volumn 17, Issue 11, 2011, Pages 1653-1658

  Martinez, T S ^a,b   Figueira, M M N R ^b   Costa, A V ^a   Goncalves M A ^a   Goulart, L R ^c,d   Goulart, I M B ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b School of Medicine   (Brazil)

^c FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Buccal swab; Household contacts; Leprosy; Molecular epidemiology; Patients

Indexed keywords

BACTERIAL DNA; BACTERIUM ANTIBODY; PGL 1 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL TRANSMISSION; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOUSEHOLD; HUMAN; HUMAN TISSUE; LABORATORY TEST; LEPROSY; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; ORAL BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BACILLI (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM LEPRAE;

EID: 80054088026     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03453.x     Document Type: Article

References (27)

1. World Health Organization (WHO). Global leprosy situation. Wkly Epidem Rec 2009; 84: 333-340.
2. Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five-group system. Int J Lepr 1966; 34: 255-273.
3. Pfaltzgraff RE, Bryceson A. Clinical leprosy. Hastings RC, ed., Leprosy. New York: Churchill Livingstone, 1985; 134-176.
4. Noordeen SK. The epidemiology of leprosy. Hastings RC, ed., Leprosy. New York: Churchill Livingstone, 1985; 15-30.
5. Moet FJ, Meima A, Oskam L, Richardus JH. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. Lepr Rev 2004; 75: 310-326.
6. Rees RJW, MCDougall AC. Airbone infection with Mycobacterium leprae in mice. J Med Microbiol 1977; 10: 63-68.
7. Ramaprasad P, Fernando A, Madhale S et al. Transmission and protection in leprosy: indications of the role of mucosal immunity. Lepr Rev 1997; 68: 301-315.
8. Reis SRA, Viana LC, Souza VF, Marchionni VMT. Manifestações Orais da Hanseníase. Rev Fac Odontol UFBA 1996; 17: 53-58.
9. D'Abreu PC, Durães SMB, Estrela RR, Baltazar MCNP, Rochael MC. Hanseníase virchowiana diagnosticada através de exame histopatológico de lesão oral em paciente com pênfigo foliáceo. An Bras Dermatol 2000; 75: 339-346.
10. Costa LCV, Andrade KLC, Carmo MAV, Ferreira MAA, Garrocho AA. Manifestações bucofaciais da hanseníase. Rev CROMG 2002; 8: 191-197.
11. Goulart IMB, Goulart LR. Leprosy: diagnostic and control challenges for a worldwide disease. Arch Dermatol Res 2008; 300: 269-290.
12. Santos GG, Marcucci G, Guimarães Júnior J, Margarido LC, Lopes LHC. Pesquisa de Mycobacterium leprae em biópsias de mucosa oral por meio da reação em cadeia da polimerase. An Bras Dermatol 2007; 82: 245-249.
13. Jopling WH, McDougall AC. Manual de Hanseníase. Rio de Janeiro/São Paulo: Atheneu, 1991: 61.
14. Lobato J, Silva DA, Mineo TW et al. Detection of immunoglobulin G antibodies to Neospora caninum in humans: high seropositivity rates in patients who are infected by human immunodeficiency virus or have neurological disorders. Clin Vaccine Immunol 2006; 13: 84-89.
15. Goulart IMB, Reis EM, Nunes MM et al. Sorologia e PCR quantitativa na classificação clínica de Ridley-Jopling da hanseníase. Seixas J, Cerasoli J, ed., UFU, ano 30 tropeçando universos (artes, humanidades, ciências). Uberlândia: EDUFU, 2008; 529-553.
16. TM real-time PCR for rapid detection and quantitation of Mycobacterium leprae in skin specimens. FEMS Immunol Med Microbiol 2008; 54: 263-270.
17. BRASIL. Ministério da Saúde. Portaria no 125/SVS-SAS de 2009. Brasília, 2009.
18. Goulart IMB, Cardoso AM, Santos MS, Gonçalves MA, Pereira JE, Goulart LR. Detection of Mycobacterium leprae DNA in skin lesions of leprosy patients by PCR may be affected by amplicon size. Arch Dermatol Res 2007; 299: 267-271.
19. Patrocínio LG, Goulart IMB, Goulart LR, Patrocínio JA, Ferreira FR, Fleury RN. Detection of Mycobacterium leprae in nasal mucosa biopsies by the polymerase chain reaction. FEMS Immunol Med Microbiol 2005; 44: 311-316.
20. Lombardi C, Suárez REG. Epidemiologia da Hanseníase. Talhari S, Neves RG, eds, Hanseníase. Manaus: Gráfica Tropical, 1997; 127-136.
21. Cho SN, Yanagihara DL, Hunter SW, Rea TH, Gelber RH, Brennan PJ. Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in the serodiagnosis of leprosy. Infect Immun 1983; 41: 1077-1083.
22. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev 2006; 19: 338-381.
23. Klatser PR, Van Beers S, Madjid B, Day R, de Wit MY. Detection of Mycobacterium leprae nasal carriers in populations for which leprosy is endemic. J Clin Microbiol 1993; 31: 2947-2951.
24. Goulart IMB, Souza DOB, Marques CR, Pimenta VL, Gonçalves MA, Goulart LR. Risk and protective factors for leprosy development determined by epidemiological surveillance of household contacts. Clin Vaccine Immunol 2008; 15: 101-105.
25. Cho SN, Kim SH, Cellona RV et al. Prevalence of IgM antibodies to phenolic glycolipid I among household contacts and controls in Korea and the Philippines. Lepr Rev 1992; 63: 12-20.
26. Baumgart KW, Britton WJ, Mullins RJ, Basten A, Barnetson RS. Subclinical infection with Mycobacterium leprae- a problem for leprosy control strategies. Trans R Soc Trop Med Hyg 1993; 87: 412-415.
27. Van Beers S, Hatta M, Klatser PR. Seroprevalence rates of antibodies to phenolic glycolipid I among schoolchildren as an indicator of leprosy endemicity. Int J Lepr Other Mycobact Dis 1999; 67: 243-249.